Neurocrine Biosciences Inc
Closed
SectorHealthcare
177.02 -2.05
Overview
Share price change
24h
Min
174.14
Max
180.28
Income | 44M 198M |
|---|---|
Sales | 9M 815M |
P/E Sector Avg | 26.785 60.549 |
EPS | 1.94 |
Profit margin | 24.297 |
Employees | 2,000 |
EBITDA | 19M 254M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +10.28% upside |
Next Earnings | 30 Jul 2026 |
|---|
Market Cap | 4B 18B |
|---|---|
Previous open | 179.07 |
Previous close | 177.02 |
News Sentiment
By Acuity
50%
50%
167 / 342 Healthcare
Neurocrine Biosciences Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Neurocrine Biosciences Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 199.11 USD 10.28%
High 246 USD
Low 144 USD
Based on 22 Wall Street analysts offering 12 month price targets forNeurocrine Biosciences Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$